Dow (DOW) Q1 2026 earnings review
Cash Flow Surges on Legal Payout, but Core Operations Remain Depressed
Dow broke its year-long sequential revenue decline, posting $9.79B in 26Q1, but year-over-year metrics show a company still navigating a brutal downcycle. Operating EBIT decelerated 33% YoY to $154M, and Operating EPS flipped to a negative -$0.14. While management highlighted a massive $1.1B in operating cash flow, this figure is a mirage—it was artificially inflated by a one-time litigation payment from NOVA Chemicals, moving in the exact opposite direction of GAAP Net Income, which collapsed to a -$445M loss. The 'Transform to Outperform' cost-cutting program is providing necessary tailwinds, but severe pricing pressure (-7% YoY) and volume disruptions from the Middle East conflict continue to erode integrated margins.
🐂 Bull Case
Management signaled that the margin backdrop began to positively inflect in March, driven by global supply constraints. This suggests the vicious cycle of price deflation may be reversing.
Performance Materials & Coatings was the lone bright spot, with Operating EBIT surging 138% YoY to $117M. Volume grew 2%, fueled by strong demand in downstream silicones for electronics and home/personal care.
🐻 Bear Case
Despite higher polyethylene volumes from the new Freeport facility, Packaging & Specialty Plastics saw Operating EBIT plunge 39% YoY. A steep 9% drop in local prices crushed integrated margins.
Industrial Intermediates & Infrastructure continues to bleed, posting a $118M operating loss. The segment suffered a 4% volume decline, directly impacted by the Middle East conflict and the shutdown of a higher-cost upstream PO unit.
⚖️ Verdict: 🔴
Bearish. The headline operating cash flow number masks severe operational weakness. With Operating EPS turning negative, local prices down 7% YoY, and a massive $292M charge for Sadara liabilities, the core business continues to deteriorate despite management's aggressive self-help cost reductions.
Key Themes
Operating Cash Flow and Net Income Moving in Opposite Directions
A major red flag: Operating Cash Flow surged to $1.12B (up $1.02B YoY), but this directly contradicts GAAP Net Income, which decelerated further into the red (-$445M vs -$290M YoY). This artificial cash generation was heavily driven by the receipt of a litigation payment from NOVA Chemicals and working capital timing, not operational execution. Investors should not mistake this cash flow spike for an operational turnaround.
P&SP Margin Compression Accelerating
Packaging & Specialty Plastics, historically Dow's profit engine, saw Operating EBIT drop from $342M to $208M YoY. Despite bringing new Freeport polyethylene capacity online to boost volume, a 9% local price decline and the mid-2025 idling of an EMEAI cracker wiped out all leverage, driving severe integrated margin compression.
Data Center and Electronics Demand Offsetting Weakness
Specific product innovation and end-market targeting are paying off in isolated pockets. Industrial Solutions reported higher volumes driven by recent alkoxylation investments and a surge in demand for data center applications. Simultaneously, PM&C capitalized on electronics applications globally, pushing segment volume up 2%.
Transform to Outperform Program Taking Root
Dow's aggressive structural reengineering plan is beginning to bear fruit. Tailwinds from the cost reduction program were cited across all three major segments in 26Q1, acting as the primary line of defense against the $76M YoY drop in overall Operating EBIT. Without these self-help actions, the bottom line would have been significantly worse.
Sadara JV Liabilities Maxed Out
Dow suspended equity loss recognition for the Sadara joint venture in 26Q1 because the carrying value of liabilities reached the total existing obligations. The company took a massive $292M pre-tax charge to adjust the guarantee liability, highlighting the persistent cash drain and structural risk posed by this Middle Eastern JV.
Middle East Conflict Strangling II&I Volumes
The macroeconomic shock of the Middle East conflict directly impacted Dow's Industrial Intermediates & Infrastructure segment, heavily contributing to its 4% YoY volume decline. However, management paradoxically noted that these same global supply constraints began to positively inflect overall company pricing power by March.
Other KPIs
Reversing violently from -$581 million in the year-ago period. While optically spectacular, this was driven almost entirely by the non-recurring NOVA Chemicals litigation payment and favorable working capital movements, overshadowing $503 million in CapEx.
Decelerating from $944 million in 25Q1. This reflects the inability of volume gains in resilient packaging and downstream silicones to offset the brutal 7% overall decline in local prices.
Guidance
Reversing. While Dow did not provide explicit quantitative guidance in the release text, management emphatically stated that pricing actions and operating rates began to 'positively inflect' in March. This suggests the deep -7% to -9% YoY pricing deflation seen in recent quarters is reversing into a more constructive pricing environment for the remainder of 2026.
Key Questions
NOVA Chemicals Payment Transparency
Operating cash flow was up $1.02B YoY primarily due to the NOVA payment. What was the exact dollar amount of this cash inflow, and are there any remaining tranches to be collected in future quarters?
Sadara Guarantee Exposure
With the suspension of equity loss recognition and the $292M liability adjustment, what is Dow's absolute maximum remaining cash exposure to the Sadara guarantee over the next 12-24 months?
Transform to Outperform Execution
Cost tailwinds were cited in every segment. Can you quantify the exact dollar amount of structural savings realized in Q1 from the 'Transform to Outperform' program, and what is the targeted run-rate exiting 2026?
Middle East Disruption Costs
You cited the Middle East conflict as a driver for II&I volume declines but also a catalyst for positive pricing inflection. What is the net EBITDA impact of these geopolitical supply constraints on the total enterprise?